Author
Listed:
- Xonia Carvajal-Vergara
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
Centro Nacional de Investigaciones Cardiovasculares)
- Ana Sevilla
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Sunita L. D’Souza
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Yen-Sin Ang
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Christoph Schaniel
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Dung-Fang Lee
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Lei Yang
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Aaron D. Kaplan
(Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Eric D. Adler
(Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Roye Rozov
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- YongChao Ge
(Mount Sinai School of Medicine, New York, New York 10029, USA)
- Ninette Cohen
(Mount Sinai School of Medicine, New York, New York 10029, USA)
- Lisa J. Edelmann
(Mount Sinai School of Medicine, New York, New York 10029, USA)
- Betty Chang
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Avinash Waghray
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Jie Su
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Sherly Pardo
(Mount Sinai School of Medicine, New York, New York 10029, USA
Child Health and Development Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
- Klaske D. Lichtenbelt
(University Medical Center Utrecht)
- Marco Tartaglia
(Oncologia e Medicina Molecolare, Istituto Superiore di Sanità)
- Bruce D. Gelb
(Mount Sinai School of Medicine, New York, New York 10029, USA
Child Health and Development Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
Mount Sinai School of Medicine, New York, New York 10029, USA)
- Ihor R. Lemischka
(Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York 10029, USA)
Abstract
iPS cell model of LEOPARD syndrome Patient-specific iPS (induced pluripotent stem) cells are seen as key to modelling genetic disorders and developing new treatments for them. Now iPS cell lines have been generated by nuclear reprogramming from patients with LEOPARD syndrome, a rare developmental disorder characterized by skin lesions, heart abnormalities and deafness. Cardiomyocytes derived from the resulting LEOPARD iPS cells have hypertrophic properties resembling those typical of the disease — cardiac hypertrophy occurs in 90% of children with the syndrome. The reprogrammed cells feature extensive alterations in various signal transduction pathway components, including RAS–MAPK, some previously described in association with cardiac hypertrophy. Using these cell lines, together with robust differentiation protocols, it may be possible to identify compounds that reverse diseased cellular phenotypes.
Suggested Citation
Xonia Carvajal-Vergara & Ana Sevilla & Sunita L. D’Souza & Yen-Sin Ang & Christoph Schaniel & Dung-Fang Lee & Lei Yang & Aaron D. Kaplan & Eric D. Adler & Roye Rozov & YongChao Ge & Ninette Cohen & Li, 2010.
"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome,"
Nature, Nature, vol. 465(7299), pages 808-812, June.
Handle:
RePEc:nat:nature:v:465:y:2010:i:7299:d:10.1038_nature09005
DOI: 10.1038/nature09005
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:465:y:2010:i:7299:d:10.1038_nature09005. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.